| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Tonghua Dongbao Pharmaceutical Co. Ltd (SHG: 600867)
600867 Technical Analysis
1.5
| As on 9th Jun 2023 600867 STOCK Price closed @ 10.51 and we RECOMMEND Buy for LONG-TERM with Stoploss of 9.91 & Sell for SHORT-TERM with Stoploss of 10.71 we also expect STOCK to react on Following IMPORTANT LEVELS. |
600867STOCK Price
| Open | 10.76 | Change | Price | % |
| High | 10.84 | 1 Day | -0.42 | -3.84 |
| Low | 10.44 | 1 Week | -0.99 | -8.61 |
| Close | 10.51 | 1 Month | -1.17 | -10.02 |
| Volume | 33953329 | 1 Year | -0.33 | -3.04 |
| 52 Week High 12.34 | 52 Week Low 8.49 | ||||
SHG China Most Active Stocks
| 600839 | 4.99 | 5.72% |
| 600050 | 5.31 | 2.51% |
| 601288 | 3.68 | -0.81% |
| 601988 | 4.13 | -0.48% |
| 601333 | 3.91 | -2.01% |
| 601360 | 14.30 | 1.13% |
| 601390 | 8.15 | 1.62% |
| 601818 | 3.29 | -0.60% |
| 601138 | 19.64 | 10.03% |
| 601398 | 5.07 | -0.39% |
SHG China Top Gainers Stocks
SHG China Top Losers Stocks
| 600867 Daily Charts |
600867 Intraday Charts |
Whats New @ Bazaartrend |
600867 Free Analysis |
|
|
600867 Important Levels Intraday
| RESISTANCE | 11.28 |
| RESISTANCE | 11.03 |
| RESISTANCE | 10.88 |
| RESISTANCE | 10.73 |
| SUPPORT | 10.29 |
| SUPPORT | 10.14 |
| SUPPORT | 9.99 |
| SUPPORT | 9.74 |
600867 Forecast May 2024
| 4th UP Forecast | 13.25 |
| 3rd UP Forecast | 12.37 |
| 2nd UP Forecast | 11.83 |
| 1st UP Forecast | 11.28 |
| 1st DOWN Forecast | 9.74 |
| 2nd DOWN Forecast | 9.19 |
| 3rd DOWN Forecast | 8.65 |
| 4th DOWN Forecast | 7.77 |
600867 Weekly Forecast
| 4th UP Forecast | 11.32 |
| 3rd UP Forecast | 11.06 |
| 2nd UP Forecast | 10.90 |
| 1st UP Forecast | 10.74 |
| 1st DOWN Forecast | 10.28 |
| 2nd DOWN Forecast | 10.12 |
| 3rd DOWN Forecast | 9.96 |
| 4th DOWN Forecast | 9.70 |
600867 Forecast2024
| 4th UP Forecast | 18.49 |
| 3rd UP Forecast | 15.93 |
| 2nd UP Forecast | 14.35 |
| 1st UP Forecast | 12.77 |
| 1st DOWN Forecast | 8.25 |
| 2nd DOWN Forecast | 6.67 |
| 3rd DOWN Forecast | 5.09 |
| 4th DOWN Forecast | 2.53 |
Tonghua Dongbao Pharmaceutical Co. Ltd ( SHG China Symbol : 600867 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
600867 Business Profile
Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The company has a strategic alliance with Adocia. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China. Address: Dongbao New Village, Tonghua, China, 134123
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service